RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 28, Issue 9, Pages 4158-4168
Publisher
FASEB
Online
2014-06-16
DOI
10.1096/fj.14-255711
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Possible involvement of PI3K-dependent pathways in the increased VEGF120 release from osteoblastic cells preloaded with palmitate in vitro
- (2014) Rie Moriya et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- P300 regulates the human RLIP76 promoter activity and gene expression
- (2013) Archana Sehrawat et al. BIOCHEMICAL PHARMACOLOGY
- Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
- (2013) Gabriel Limaverde-Sousa et al. CANCER TREATMENT REVIEWS
- In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells
- (2013) Wennan Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxia-inducible Factor-1α (HIF-1α) Promotes Cap-dependent Translation of Selective mRNAs through Up-regulating Initiation Factor eIF4E1 in Breast Cancer Cells under Hypoxia Conditions
- (2013) Tingfang Yi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis
- (2013) Jieping Yan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Endogenous oxidative stress, but not ER stress, induces hypoxia-independent VEGF120release through PI3K-dependent pathways in 3T3-L1 adipocytes
- (2013) Kazuto Takahashi et al. Obesity
- RALBP1/RLIP76 Depletion in Mice Suppresses Tumor Growth by Inhibiting Tumor Neovascularization
- (2012) S. Lee et al. CANCER RESEARCH
- RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer
- (2012) Kathryn Leake et al. PLoS One
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- HIF-1: upstream and downstream of cancer metabolism
- (2009) Gregg L Semenza CURRENT OPINION IN GENETICS & DEVELOPMENT
- HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
- (2009) G. Semenza CURRENT PHARMACEUTICAL DESIGN
- Tumor Angiogenesis in Melanoma
- (2009) Alexander G. Marneros HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis
- (2009) Barbara Muz et al. ARTHRITIS RESEARCH & THERAPY
- Regression of prostate cancer xenografts by RLIP76 depletion
- (2008) Sharad S. Singhal et al. BIOCHEMICAL PHARMACOLOGY
- RLIP76 and Cancer
- (2008) S. Awasthi et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More